Login / Signup

Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin.

Layla VeleanuLaurence LamantDavid Sibonnull null
Published in: The New England journal of medicine (2024)
Keyphrases
  • hodgkin lymphoma
  • advanced non small cell lung cancer